Michael Franken, President, Biosimilars Busines at MOMENTA PHARMACEUTICALS INC (MNTA), sold 512 shares at $22.37 ($11K) on 2015-06-11, disclosed to the SEC on 2015-06-15.
Scheduled sale ($11k) by President, Biosimilars Busines under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2015-08-14 | $447K | — | Filing → |
| MNTA | SELL | 2015-03-13 | $8K | — | Filing → |
| MNTA | SELL | 2014-12-12 | $25K | — | Filing → |